tuneTypical Dose
2-4 applications/day
Botanical
Arnica montana
tuneTypical Dose
2-4 applications/day
watchEffect Window
Hours to days
check_circleCompliance
WADA NOT PROHIBITED
Overview
Arnica is a botanical used for pain and inflammation management. It is taken to support joint comfort, headache frequency, or musculoskeletal recovery.
Controlled studies for some analgesic herbs show small to moderate improvements in pain and function, often in osteoarthritis or headache. Mechanisms proposed include COX, leukotriene, or TRP channel modulation. Minority evidence includes reduced muscle soreness and improved recovery biomarkers, but data are limited. Adverse effects vary by herb and can include GI irritation or liver enzyme elevations.
Topical demulcent/inflammatory symptom support for localized tissues. No role as internal nootropic enhancer.
Outcomes
Safety
Evidence
Topical arnica controlled and observational injury-care literature.
Population: Bruise and localized soreness cohorts.
Dose protocol: Labeled topical preparation use.
Key findings: Symptom reduction in some short episodes.
Notes: Endpoint subjectivity and product heterogeneity.
Symptom reduction in some short episodes.
Safety-focused resources on inappropriate oral arnica and toxicological concerns.
Population: General population safety cohorts/case reports.
Dose protocol: Oral misuse or high exposure.
Key findings: Predominantly indicates avoidance for oral/overuse.
Notes: Limited controlled data for harm due mostly to case-based reporting.
Predominantly indicates avoidance for oral/overuse.
Akay N, Sanal KO. Can Topical Agents (Arnica and Mucopolysaccharide Polysulfate) Reduce Postoperative Pain, Edema and Trismus Following Mandibular Third Molar Surgery? J Oral Maxillofac Surg. 2024;82(1):113-121. doi:10.1016/j.joms.2023.10.003. PMID:37913818.
Population: Patients undergoing impacted mandibular third molar extraction.
Dose protocol: Topical arnica gel plus standard therapy (antibiotic and NSAID) after mandibular third molar surgery.
Key findings: RCT in 60 patients found topical arnica reduced pain through postoperative day 5 and was more effective than MPSP for trismus reduction.
Notes: Single-center study. Arnica was used as adjunct to standard therapy, not standalone.
This three-arm RCT in 60 patients tested topical arnica and mucopolysaccharide polysulfate (MPSP) as adjuncts to standard therapy after impacted mandibular third molar extraction. Both agents reduced pain through postoperative day 5 compared to standard therapy alone. Arnica was more effective at reducing trismus (jaw tightness), while MPSP was superior for edema reduction. The findings support topical arnica as a useful adjunct for post-surgical pain and jaw mobility recovery.